MjLink Cannabis Business News and Press
Mississippi Gov. Tate Reeves told reporters at the state capitol Feb. 1 that he is undecided on whether he will sign a medical cannabis legalization bill into law, but luckily for the state’s patient base, the legislation is expected to become law no matter how Reeves responds, as it passed the Legislature with veto-proof majorities.
RELATED: Mississippi Governor’s Veto Card Trivial on Cannabis
Reeves said Tuesday that his attorneys are still reviewing the bill, according to an AP News report.
He added that he is pleased that lawmakers made some of his suggested tweaks to the legislation, including a request that legislators reduce the amount of cannabis that patients can access each month.
The bill would allow qualified patients to purchase up to 3.5 grams of cannabis per day, up to six days per week, and sets taxes on the production and sale of medical cannabis.
February 2, 2022 - PRESS RELEASE - The Colorado Department of Revenue (DOR), in conjunction with the Colorado Department of Public Health and Environment (CDPHE), is issuing a health and safety advisory due to the identification of potentially unsafe levels of total yeast and mold contamination in retail infused pre-roll marijuana produced by DJR Colorado, LLC DBA High Level Health (DJR Colorado). The CDPHE and DOR deem it a threat to public health and safety when marijuana is found to have total yeast and mold levels above the acceptable limits established in Colorado Marijuana Rule 4-115.
The DOR has identified infused pre-roll marijuana from production batches produced by DJR Colorado that were confirmed to have failed contaminant testing. Based on the investigation, the DOR has identified additional production batches of infused pre-roll marijuana that were created using the same process that led to contaminant testing failures in the production batches listed below. Out of an abundance of caution, these additional production batches are included in this advisory and listed as potentially contaminated production batches.
Consumers who have these affected products in their possession should destroy them or return them to the retail store from which they were purchased for proper disposal. Consumers who experience adverse health effects from consuming the product should seek medical attention immediately and report the event to the Marijuana Enforcement Division by submitting a MED Reporting Form.
All affected marijuana should have a label affixed to the container that, at a minimum, indicates the license number of the retail marijuana business that manufactured the infused pre-roll marijuana, the production batch number, and the product name assigned to the marijuana. Consumers should check the label of their infused pre-roll marijuana for the following license number, product name, and production batch number.
Retail Marijuana Products Manufacturer License: 404R-00072
Contaminated Production Batches:
LAS VEGAS – Feb. 1, 2021 – PRESS RELEASE – The Source+, an award-winning cannabis company with dispensaries in the Las Vegas Valley and Reno, will support national nonprofit, Minorities for Medical Marijuana (M4MM), throughout the month of February to bring awareness to the organization’s commitment to cultivating a culturally inclusive cannabis environment.
Now through Monday, Feb. 28, customers may round up their purchases while shopping at The Source+ to directly support M4MM. The Source+ will also accept direct donations for the organization at each of its four locations throughout Nevada.
“Black History Month is a wonderful time to celebrate excellence and achievement in the Black Community,” said M4MM Western Regional Director, Nicole Buffong. “We are thrilled to be acknowledged and celebrated for the successful advocacy, outreach, education and training we provide our community on a daily basis. Thank you to The Source+ for supporting our efforts in such a meaningful way.”
In addition to The Source+’s roundup initiatives, the company, in partnership with M4MM, will host a record sealing event to provide education and resources to the Las Vegas community about sealing criminal records, including recently decriminalized marijuana convictions. The Source+ will host the event at its Sahara store in Las Vegas, located at 2550 S. Rainbow Blvd, from noon to 4 p.m. on Saturday, March 19, as well as its Reno store, located at 5270 Longley Ln Suite 103, from noon to 4 p.m. on Saturday, March 26.
“Minorities have and continue to be affected by the War on Drugs, and as the cannabis industry progresses, we have an obligation to do better,” said Simon Nankervis, CEO of The Source+. “The Source+ is proud to support Minorities for Medical Marijuana and their dedication to tackling diversity and inclusion in the cannabis industry. We look forward to uniting our community to fund this important cause.”
Al Harrington, 16-year NBA veteran and co-founder and CEO of Viola Brands, is on the forefront of the fight for social equity in the cannabis industry—a fight that he doesn’t see ending any time soon.
Viola recently partnered with the Cleveland School of Cannabis to launch its own education platform, the Harrington Institute, which aims to create economic opportunities for individuals, especially those in Black communities, who are looking to enter the market.
In early 2020, the company launched a separate social equity initiative, Viola Cares, in partnership with a national non-profit organization, Root & Rebound. The initiative aims to offer education, expungement and incubation programs to help increase diversity in the industry.
“We’re just overall trying to help in any way that we can,” Harrington tells Cannabis Business Times. “There are so many holes in the boat, to try to fix them all is tough. For us, we just try to put ourselves in the position to be an asset to the industry, and especially to people of color, as we try to navigate our future in a space [where] we deserve a seat at the table.”
Here, Harrington provides an update on Viola’s social equity initiatives and discusses what’s working well, what isn’t, and how the industry can come together to support minority-owned businesses in the quest for diversity.
PORTLAND, Ore., Feb. 1, 2022 - NEWS RELEASE - Phylos, a modern crop science company developing advanced cannabis and hemp genetics, announces the close of its growth funding round totaling $7.6 million led by Merida Capital Holdings. Other major investors in the round include Accomplice and Entourage Effect Capital. This infusion further validates a refreshed direction and executive team. Funds will be used in part to expand sales and marketing efforts for Phylos' market-validated cannabis and hemp genetics. Mina Mishrikey, senior partner at Merida, will be joining the Phylos board of directors.
Leading towards industry growth and scalability, the new executive team will leverage proprietary research and technology to drive innovation in hemp and cannabis science and breeding. The team includes Ralph Risch (CEO), Alisha Holloway (chief scientific officer), and Dylan Anderson (chief financial officer).
"The cannabis industry, relying by and large on cloning techniques, has seen relatively little seed genetics development to date, and that is changing as we speak," Mishrikey says. "Phylos' next-generation technology will allow cultivators to grow healthier, more consistent crops with amplified, diverse cannabinoid and terpene profiles. We are confident that Phylos is at the forefront of this movement towards a healthier plant and a more sustainable industry."
During its restructuring, Phylos met several notable milestones at the 80,000-square-foot state-of-the-art breeding, genomics, and chemotype analysis facility it shares with its cultivation partner Progressive Plant Research (PPR). This includes the development of dozens of novel cultivars and discovery of genetic markers for numerous high-value cannabis and hemp traits. The company has expanded its flagship AutoCBD autoflower hempseed to four varieties and has developed ground-breaking low-touch, high-yield, and disease-resistant early maturation cannabis seed genetics for commercial-scale grows.
"The future of cannabis cultivation is in elite genetics and F1 hybrid seeds," Risch says. "Cannabis and hemp production across the U.S. is rapidly scaling to meet the needs of consumers seeking affordable, consistent, and memorable experiences. High-quality, stable genetics that increase the productivity of each square foot of licensed canopy with fewer touches of the plant are now a requirement. We are passionate to prove how stable genetics create a foundation for products across the industry."
Phylos will continue its commitment to collaborate with breeders through royalty-bearing licensing deals to ensure they're fairly compensated for their dedication to the advancement of cannabis and hemp, protecting IP to promote innovation, and support funding research to further knowledge of the cannabis genome. The company also provides no-cost technology licensing for academic institutions and non-profits, specifically for research purposes.
You can see more on Phylos' latest developments, solutions and partnerships at phylos.bio.]]>The infrastructure tied to awarding 26 highly sought-after social equity licenses in Arizona is still intact, at least for now.
Maricopa County Superior Court Judge Randall Warner dismissed a lawsuit challenging the state’s rules for issuing the adult-use cannabis retail licenses, ruling Tuesday that the rules published by the Arizona Department of Health Services (ADHS) satisfy provisions set forth by Proposition 207, the state’s 2020 voter-approved ballot measure for adult use.
Leaving leeway in the groundwork, Prop. 207 established that those licenses be awarded to applicants impacted by prohibition.
Warner said the law provided ADHS flexibility on how to write and implement rules, The Associated Press reported. As drafted, those rules “are reasonably designed to meet its objectives,” the judge concluded.
The licenses in question are tied to applicants who have recently lived in 87 qualifying ZIP codes, ADHS officials announced in October.
The South Dakota House rejected a bill Jan. 31 that would have allowed local governments to opt out of hosting medical cannabis businesses, according to a KELO report.
House Bill 1095, which would have authorized cities and counties to pass exemption ordinances, was narrowly shot down in a 31-33 vote, the news outlet reported.
The legislation needed at least 36 votes to advance to the South Dakota Senate.
RELATED: South Dakota Lawmakers Divided on Allowing Home Cultivation in Medical Cannabis Program
South Dakota voters approved Initiated Measure 26 in the 2020 election to legalize medical cannabis. The measure received 70% support and passed in 63 of the state’s 66 counties, KELO reported.
A new bill in the California Legislature would classify unlicensed cannabis cultivation as a felony, rolling back part of the state’s 2016 voter-approved initiative that legalized adult-use and made growing any number of plants without a license a misdemeanor, according to a Forbes report.
Under A.B. 1725, filed by Rep. Thurston Smith (R-Apple Valley), growing more than six plants without a permit would be reclassified as a felony offense, punishable by up to three years in jail.
To go to Gov. Gavin Newsom’s desk, the legislation requires a two-thirds majority in the Legislature, since it amends a voter-approved initiative.
Thurston’s bill aims to “combat illegal marijuana grows that have been proliferating throughout the rural High Desert communities,” according to a press release from his office.
“These illicit growers have been operating with impunity, knowing that the law allows them to grow with barely a hindrance,” Thurston said in a public statement. “For far too long, Sacramento has been soft on crime, and the illicit market has exploded with massive unlicensed grows popping up all around the state."
Upon consummation of the acquisition, Verano’s footprint will span 18 states, with active operations in 15, including 17 cultivation facilities totaling 1.3 million square feet of cultivation capacity and 111 active dispensariesVerano will obtain one of only 10 vertically integrated licenses in New York, which includes one cultivation license, four active dispensaries and four additional dispensaries planned in high-traffic locationsVerano will acquire one of only two vertically integrated licenses in Minnesota, which includes one cultivation license and eight active dispensariesIn New York, the company will gain delivery service across the New York City area via a dispensary on Queens Boulevard centrally located next to the Long Island Expressway, Citi Field and LaGuardia Airport; along with three high-traffic dispensaries—in a busy shopping district in White Plains; in Albany adjacent to the University of Albany campus and Colonie Center Mall; and in Johnson City across from the Oakdale MallIn Minnesota, Verano will obtain eight dispensaries, including one in the heart of downtown Minneapolis and four more across the Minneapolis-St. Paul metro area; in locations covering the cities of Duluth and Rochester; and in Moorehead, which is situated in the Fargo, N.D., metro areaBetween 2022 and 2026, these net new markets are expected to generate combined revenue of more than $13.8 billion, according to BDSA data
CHICAGO, Feb. 1, 2022 – PRESS RELEASE – Verano Holdings Corp. and Goodness Growth Holdings Inc. have entered into a definitive arrangement agreement (the “arrangement agreement”) pursuant to which Verano will acquire all of the issued and outstanding shares of Goodness in an all-share transaction valued at approximately $413 million on a fully diluted basis.
Under the terms of the arrangement agreement, it is expected that each holder of Goodness subordinate voting shares will receive 0.22652 of a Verano Class A subordinate voting share for each Goodness subordinate voting share held and each holder of Goodness multiple voting shares and Goodness super voting shares will receive 22.652 Verano shares for each Goodness multiple voting share and Goodness super voting share held, respectively.
Goodness’ active operations include 18 dispensaries; five cultivation and processing facilities; a research and development facility; and the Vireo, 1937, LiteBud, Kings & Queens, Hi-Color, and Amplifi product brands. The acquisition of Goodness is expected to expand Verano’s operational footprint with the addition of the New York, Minnesota and New Mexico markets, strategically increasing the company’s presence in the Northeast, Midwest and Southwest, while adding a suite of established cannabis brands to the company’s portfolio.
Management Commentary
“We have always viewed New York as a strategic market to solidify our existing East Coast presence, particularly ahead of the state’s adult-use rollout, as we further expand the Verano platform and exceed a milestone of operating more than 100 dispensaries across the country,” Verano founder and CEO George Archos said. “Adding the New York, Minnesota and New Mexico markets to our portfolio, with full vertical integration, provides Verano with a solid foundation for future growth. We’re excited to welcome new colleagues to the Verano family and look forward to serving patients and consumers in communities across these great states.”
DENVER, Feb. 1, 2022 /CNW/ - PRESS RELEASE - Schwazze, has announced the addition of key roles to support the company's significant expansion within manufacturing, cultivation, and information technology.
As Vice President of Manufacturing and Supply Chain, David Kaufman joined the leadership team from Carlex Glass where he was responsible for global operations. Kaufman is a seasoned executive with experience identifying and yielding multimillion-dollar improvements in operations and supply chain through LEAN manufacturing, procurement, and distribution strategies. He had full P&L responsibility for the European business segment where he led a significant turnaround in operating performance and financial improvement. Kaufman holds a distinguished certificate in general management from the Darden School of Business at the University of Virginia, MBA from the University of St. Francis, and BS in Chemistry from Purdue University.
Steven Liedtke joins Schwazze as Vice President, Information Services. Liedtke is an experienced Information Technology Executive with more than 25 years of leadership experience across industry sectors such as: CPG, Food & Beverage, Retail, and High Technology industries, including The Hain Celestial Group, The Whitewave Foods Company and Maines Group. Technology is a key pillar in Schwazze's growth strategy to help drive digital transformation, operational efficiencies, and synergies. With his M&A systems integration experience, Liedtke brings the expertise Schwazze needs in this period of significant organic and new acquisition growth.
The third key addition to the leadership team is in cannabis cultivation. Robert Piziali joins Schwazze as Vice President, Cultivation, overseeing its grow operations. Piziali was formerly the President of FarmPerfect, a cannabis farm management company based in Mendocino County, Calif. He has 20 years of experience in operations management and, prior to cannabis, comes from the wine industry where he was involved in all aspects – from the vineyard to the cellar, to tasting rooms and retail operations. He was also the co-founder and president of FLO Wine, which he launched nationally in chains including Wal-Mart, Costco, Target, Jewel-Osco, and Albertsons. Piziali has an MBA from University of North Carolina, Chapel Hill and a BA in Psychology from Rollins College.
"We are excited about the key additions to our operational leadership team. Kaufman, Piziali and Liedtke bring a wealth of knowledge and experience in their respective areas which are both critical to Schwazze's growth strategy in manufacturing, grow operations, distribution and digital commerce," said Nirup Krishnamurthy, chief operating officer. "We continue to be proud of what we've built in Colorado since 2019 and look forward to our continued expansion."
]]>LAS VEGAS (Feb. 1, 2022) – Registration has officially opened for Cannabis Conference, the cannabis industry’s leading conference for cannabis cultivators, retailers, extraction professionals and hemp growers.
Cannabis Conference 2022, which will return to the Paris Las Vegas Hotel & Casino from Aug. 23-25, 2022, is presented by award-winning media brands Cannabis Business Times, Cannabis Dispensary and Hemp Grower. The industry event will bring together 4,000 current and prospective cannabis business operators, university professors, consultants, and technology and solutions providers from across the U.S. and around the globe for three dynamic days of education and expo.
Cannabis Conference’s education program will address the most pressing issues plant-touching businesses face, as well offer tangible solutions operators can implement into their own businesses. Sessions are being crafted with the assistance of Cannabis Conference Advisory Board members, who come from some of the most successful and innovative companies and organizations in the space, such as Cresco Labs, Flower One, Green Rush Consulting, Sherbinskis, the Minority Cannabis Business Association, Curaleaf, Merida Capital, Papa & Barkley, and many more.
Cannabis Conference will also feature 240-plus solutions providers in its 85,000-square-foot exhibit hall, including experts in: horticultural lighting, nutrients, growing media, pest control, structures, drying and storage, IT services, marketing solutions, facility design, accounting and finance, POS software, packaging and labeling, and much more.
“The global legal cannabis market continues to grow and evolve at breakneck speed,” Cannabis Conference Executive Director Jim Gilbride said. “With new markets emerging, new challenges arising, and new solutions coming to the forefront in 2022, it’s more important than ever for cannabis businesses to connect and discover ways to build and strengthen competitive, compliant, and profitable businesses.”
Registration rates range from $99 (Expo Only) to $399 (All-Access Pass). Detailed pricing and registration information can be found at www.cannabisconference.com/page/prices.
In one of his final stints on Capitol Hill, Rep. Ed Perlmutter isn’t ready to call it quits on banking reform for the cannabis industry.
The Colorado Democrat, who assumed office in 2007, announced earlier this month that he won’t seek reelection come November, attracting the attention of those throughout the cannabis industry, many of whom have backed his fight to provide clarity and safe harbor to financial institutions servicing cannabis clients.
Perlmutter, 68, is the chief author of the Secure and Fair Enforcement (SAFE) Banking Act, which has passed the U.S. House five times since 2019, including twice as a standalone bill, and most recently as an amendment to the National Defense Authorization Act in September 2021, before it was later removed from the military spending package during negotiations between the House and Senate.
RELATED: U.S. House Adds SAFE Banking to Defense Spending Package
All five times SAFE Banking passed the House, it stalled before making headway in the Senate. But behind broad bipartisan support in his chamber, including a 321-101 roll call vote in April, Perlmutter isn’t giving up on its complete passage.
In his most recent move, Perlmutter is now fixing to attach SAFE Banking as an amendment to the America COMPETES (Creating Opportunities to Meaningfully Promote Excellence in Technology) Act of 2022, he announced Jan. 28.
Republican lawmakers in Virginia are considering changes to the state’s adult-use cannabis law, according to an AP News report.
Legislators have said that while they will not seek to overturn the law, they do want to tweak the statute that passed last year to legalize cannabis possession and sales.
Changes might include launching retail sales earlier and eliminating a provision that would give licensing preference to people with past cannabis-related convictions, AP News reported.
Former Virginia Gov. Ralph Northam signed the state’s adult-use legalization bill into law last spring after the Legislature approved last-minute amendments to expedite the cannabis possession and home grow measures to take effect July 1, 2021. The legislation called for sales to launch in 2024, but also included a reenactment clause that requires the Legislature to reauthorize the bill before it can take effect.
RELATED: New Governor, Reenactment Clause Could Mean Changes to Virginia’s Adult-Use Cannabis Law
The Illinois Supreme Court has denied a request from a cannabis company to allow the state to name the winners of craft grow licenses that have been held up until pending litigation is settled, according to the Chicago Tribune.
One of the applicants for the craft grow licenses, 1837 Craft Grow LLC, had asked the court to modify an order from a lower court that bars state officials from naming the licensees until litigation is settled.
The case holding up the licenses centers on 13 companies that sued the state to challenge the licensing process after their applications for craft grow licenses were disqualified.
A state law required Illinois officials to issue 60 new craft grow licenses by Dec. 21, 2021, but Cook County Judge Neil Cohen and Sangamon County Judge Gail Noll have ordered that the licenses cannot be issued until the lawsuit is settled.
A hearing in the case is scheduled for March 10.
OAKLAND,Calif. and HALF MOON BAY, Calif., Jan. 31, 2022 – PRESS RELEASE – Dark Heart Industries, a California cannabis geneticscompany, announced the world’s first seedless triploid cannabis for commercialgrowers. Dark Heart’s PistilGuard technology produces triploid cannabis seedsand clones that essentially cannot produce seed, even when directly exposed topollen. This technology innovation means that triploid cannabis can be grown onthe same scale as corn, wheat or industrial hemp.
“Ourcannabis genetics using PistilGuard triploid technology are an industry first,”said Dan Grace, founder and CEO of Dark Heart Industries and Dark HeartNursery. “The ability to grow THC-rich cannabis from sterile, triploid seedsand clones that are guaranteed to produce virtually seedless plants is a hugewin for the cultivators we support. Pollen-proof cannabis, and the advantagesit offers, will help move cannabis production from artisanal cultivation tolarge-scale agriculture.”
"Thedevelopment of triploid seedless varieties has been a huge step forward in manycommercial crops including watermelon, banana and apples,” said Ken Owens, Ph.D.,vegetable breeder and former president of Magnum Seeds. “This trait'sintroduction in cannabis is a real breakthrough that will allow higher yields,reduced costs as well as improved aromatic and chemical qualities of the crop.All this leads to higher profitability and control of your crop.”
Owensadded, “Now that scientists at Dark Heart have developed the core technology,they'll be able to introduce new seedless, triploid-based strains and cultivarsthrough traditional breeding that should bring cannabis production to a wholenew level very soon.”
Cannabis Genetics 1970s – 2022
Thepresence of seeds in cannabis plants decreases the density of cannabinoids andterpenes, leading to low-THC production, loss of yield and diminished bagappeal. So, breeders have long sought ways to remove seeds from cannabis.
Names: Lex Corwin and Blake Kelley
Columbus, OH – PRESS RELEASE – Today the Coalition to Regulate Marijuana Like Alcohol was notified by the Ohio Secretary of State’s office that they have submitted sufficient valid signatures to qualify the initiative for the next phase of the process. The news comes after CRMLA submitted 29,918 additional signatures in support of an initiated statute legalizing the adult use of marijuana to the Ohio Secretary of State’s office on Jan. 13. Local boards of elections determined that 16,904 of the additional signatures were valid.
Ohio Secretary of State Frank LaRose has transmitted the initiative to Ohio legislators, kicking off a four-month process during which legislators will have the opportunity to debate and vote on the initiative. If legislators fail to take action on the initiative, the Coalition to Regulate Marijuana Like Alcohol will have the opportunity to collect an additional 132,877 signatures this summer in order to present the issue to Ohio voters on the Nov. 8, 2022, ballot.
“We are ready and eager to work with Ohio legislators over the next four months to legalize the adult use of marijuana in Ohio,” said spokesman Tom Haren. “We are also fully prepared to collect additional signatures and take this issue directly to voters on Nov. 8, 2022, if legislators fail to act.”
In New Jersey, adult-use cannabis sales have been on the calendar for Feb. 22: Opening Day in the state’s newly legalized marketplace.
Now, regulators are dialing back the anticipation.
“There’s still a lot to be done,” Jeff Brown, the executive director of the state Cannabis Regulatory Commission, told NJ Cannabis Insider this week. “Feb. 22 is not a concrete date to open. There is no firm commitment on timing of when recreational sales will begin.”
Brown pointed to a lack of “municipal approval” as one major challenge to getting dispensaries up and running next month. Without local governments signing off on business owners’ license applications, that market cannot get off the ground for customers.
By and large, the businesses clamoring to open are the same ones already operating in the medical marketplace, and they’re insisting to state regulators that supply will not be an issue. Once they’re given the formal green light, those licensed businesses have told the local media that they’ll be ready to serve recreational customers right away.
There’s no enforcement mechanism for the Feb. 22; the date is more symbolic or aspirational than anything.
The Minority Cannabis Business Association (MCBA) is set to release its National Cannabis Equity Report and National Cannabis Equity Map Feb. 10 to present data it has collected on social equity programs across the country, and MCBA Executive Director Amber Littlejohn said the data paints a bleak picture of social equity in the industry.
“When you start to look beyond these social equity provisions, you start to see how these merit-based and lottery selection systems have the inequities and the barriers to entry baked into them in more subtle and quiet ways,” she told Cannabis Business Times. “We’re really hoping that this is an opportunity for reflection for the industry as a whole on how they can align their values with their actions.”
The National Cannabis Equity Report and National Cannabis Equity Map, made possible with support from the ArcView Group and in association with Weedmaps and Parallel, provide critical data from social equity programs, as well as other policies that impact equity in state and municipal medical and adult-use markets.
Littlejohn said the project was initially inspired by the questions she has received in the two years since she began leading MCBA.
“One of the most frequent questions that I’ve been getting over the past two years since I’ve been with MCBA—almost three years now—is how many social equity programs are there and what do they do?” she said. “The project itself originally started with us wanting to take a look at all of the social equity programs and understand which programs did what and be able to provide an overview so people could see what was out there and what was being done.”
A new bill introduced in California would set new deadlines for courts to dismiss and seal cannabis-related convictions after a Los Angeles Times’ investigation revealed that tens of thousands of Californians are still stuck with the crimes on their records.
A 2018 law required the state to clear cannabis-related convictions, but many courts have been slow to act, according to the news outlet, which reported that at least 34,000 records have not been fully processed.
Court officials have blamed several factors for the delays, including the COVID-19 pandemic, staffing shortages and outdated case management systems, the Los Angeles Times reported.
“California made a promise,” the bill’s author, Assemblymember Mia Bonta (D-Alameda), told the news outlet. “I’m focused on making sure that California keeps its promises. This bill would allow us to automatically seal qualifying cannabis criminal records.”
Bonta’s legislation would give courts a Jan. 1, 2023 deadline to update case records and send them to the California Department of Justice, which manages the state’s criminal history database. The department would then have until July 1, 2023 to update its records, the Los Angeles Times reported.
